Gynecology Drugs Market: Global Industry Analysis and Forecast (2022-2029)


Gynecology Drugs Market is expected to reach US$ 25.32 Bn. at a CAGR of 7.42% during the forecast period 2029.

Gynecology Drugs Market

To know about the Research Methodology :- Request Free Sample Report

Gynecological diseases denote a diverse medical circumstances specific to the female reproductive system. The most common symptoms of gynecologic disorders comprise vaginal itching, vaginal discharge, abnormal vaginal bleeding, breast pain, pelvic pain, and lumps pain. The implication and severity of these symptoms frequently depend on age and with aging. Thus, gynecology drugs treatments is utilized for the medication of several gynecological diseases and symptomsThe report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.

The scope of the report includes a detailed study of global and regional markets for Gynecology Drugs with the reasons given for variants in the growth of the industry in certain regions.

The implementation of gynecology drugs have increased due to upsurge in frequency of gynecological diseases. Variation in lifestyle of the global female population has progressively enhanced their healthcare necessities. Constant upsurge in awareness about health and well-being has led to an increase in the demand for better gynecological treatments. Identifying this opportunity, several drug producers in global have developed new innovative gynecology treatments that have better efficiency and least side-effects. Additionally, increasing geriatric female population and economic growth are the key factors which offers beneficial opportunity to gynecology drugs market.

The report on global Gynecology Drugs market covers segments such as Therapeutics Type, Indication, Distribution Channel and Region. The Therapeutics Type segment includes Hormonal therapy and Non-Hormonal therapy. Among the therapeutics Type, Hormonal therapy is accounted for the largest xx% market share in the global Gynecology Drugs market. Based on Indication, the global Gynecology Drugs market is sub-segmented into Gynecology Cancers, Endometriosis, Female Infertility, Menopausal Disorder, Gynecology Infections, Polycystic Ovary Syndrome, Contraception (Birth Control), and Others.

Amongst them Gynecology Cancers is accounted for the largest xx% market share in the global Gynecology Drugs market. Based on Distribution Channel, the global Gynecology Drugs market is sub-segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Amongst them Hospital Pharmacies are accounted for the largest xx% market share in the global Gynecology Drugs market.

Based on regional segment, the global Gynecology Drugs market is sub-segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is projected to lead the global gynecological drugs market over the forecast period, due to the high disbursement on woman health, extensive research and development activities witnessed in the gynecology field. The rising frequency of polycystic ovarian disease and cervical cancer and increasing approval of gynecological drugs, which are also driving the gynecological drugs market growth.

Furthermore, the existence of developed countries, like U.S. and Canada, with technological advanced healthcare amenities and infrastructure are projected to further encourage the gynecological drugs market over the projected period.

Europe is expected to trail after North America in terms of growth and be the second largest gynecological drugs market in the years ahead. The extensive research and development labs in the field of gynecology, technological advancements, and numerous gynecological facilities are expected to drive the European gynecological drugs market in the future.

The Asia Pacific gynecological drugs market is projected witness a high CAGR over the defined period, due to the existence of developing economies, like India and China, strong healthcare facilities, and promotion of new gynecological drugs apart from the presence of a large patient pool in this region. Moreover, the rising consciousness of gynecological drugs due to the enormous dependence of women on these drugs is also initiating the region’s gynecological drugs market.

Key players operating in the Gynecology Drugs market are Eli Lilly and Company, Pfizer, Inc., Merck & Co., Inc., Amgen Inc., AstraZeneca, F. Hoffmann-La Roche Ltd., Allergan Plc, Sanofi, GlaxoSmithKline plc, Lupin Pharmaceuticals, Inc., Bayer AG, and Johnson & Johnson.
These companies have various product offerings and extensive distribution systems across the globe. Furthermore, entry of small players, particularly in developing markets of Asia, is being witnessed. However, rigorous regulatory framework and high-quality standards set by market leaders are expected to restrain the penetration of new entrants in the market.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding global Gynecology Drugs market dynamics, structure by identifying and analyzing the market segments and project the global market size.

Further, the report also focuses on the competitive analysis of key players by Product, price, financial position, Product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment shortly to the emerging segment in the global Gynecology Drugs market.

Gynecology Drugs Market Scope: Inquire before buying


Gynecology Drugs Market, By Therapeutics Type

• Hormonal therapy
• Non-Hormonal therapy

Gynecology Drugs Market, By Indication

• Gynecology Cancers
• Endometriosis
• Female Infertility
• Menopausal Disorder
• Gynecology Infections
• Polycystic Ovary Syndrome
• Contraception (Birth Control)
• Others

Gynecology Drugs Market, By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Gynecology Drugs Market, By Region

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America

Gynecology Drugs Market Key players

• Eli Lilly and Company
• Pfizer, Inc.
• Merck & Co., Inc.
• Sanofi
• Amgen Inc.
• Lupin Pharmaceuticals, Inc.
• AstraZeneca
• F. Hoffmann-La Roche Ltd.
• Allergan Plc.
• GlaxoSmithKline plc.
• Bayer AG
• Johnson & Johnson
• AbbVie Inc
• TherapeuticsMD Inc
• Ferring Holding SA
• Abbott

Frequently Asked Questions:

1. Which region has the largest share in Global Gynecology Drugs Market?
Ans: North America region holds the highest share in 2021.

2. What is the growth rate of Global Gynecology Drugs Market?
Ans: The Global Gynecology Drugs Market is growing at a CAGR of 7.42% during forecasting period 2022-2029.

3. What is scope of the Global Gynecology Drugs market report?
Ans: Global Gynecology Drugs Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Gynecology Drugs market?
Ans: The important key players in the Global Gynecology Drugs Market are – Eli Lilly and Company, Pfizer, Inc., Merck & Co., Inc., Sanofi, Amgen Inc., Lupin Pharmaceuticals, Inc., AstraZeneca, F. Hoffmann-La Roche Ltd., Allergan Plc., GlaxoSmithKline plc., Bayer AG, Johnson & Johnson, AbbVie Inc, TherapeuticsMD Inc, Ferring Holding SA, and Abbott

5. What is the study period of this market?
Ans: The Global Gynecology Drugs Market is studied from 2021 to 2029. 




Global Gynecology Drugs Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Gynecology Drugs Market Size, by Market Value (US$ Mn)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
5. Supply Side and Demand Side Indicators
6. Global Gynecology Drugs Market Analysis and Forecast
6.1. Global Gynecology Drugs Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America
7. Global Gynecology Drugs Market Analysis and Forecast, By Therapeutics Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Gynecology Drugs Market Value Share Analysis, By Therapeutics Type
7.4. Global Gynecology Drugs Market Size (US$ Mn) Forecast, By Therapeutics Type
7.5. Global Gynecology Drugs Market Analysis, By Therapeutics Type
7.6. Global Gynecology Drugs Market Attractiveness Analysis, By Therapeutics Type
8. Global Gynecology Drugs Market Analysis and Forecast, By Indication
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Gynecology Drugs Market Value Share Analysis, By Indication
8.4. Global Gynecology Drugs Market Size (US$ Mn) Forecast, By Indication
8.5. Global Gynecology Drugs Market Analysis, By Indication
8.6. Global Gynecology Drugs Market Attractiveness Analysis, By Indication
9. Global Gynecology Drugs Market Analysis and Forecast, By Distribution Channel
9.1. Introduction and Definition
9.2. Key Findings
9.3. Global Gynecology Drugs Market Value Share Analysis, By Distribution Channel
9.4. Global Gynecology Drugs Market Size (US$ Mn) Forecast, By Distribution Channel
9.5. Global Gynecology Drugs Market Analysis, By Distribution Channel
9.6. Global Gynecology Drugs Market Attractiveness Analysis, By Distribution Channel
10. Global Gynecology Drugs Market Analysis, by Region
10.1. Global Gynecology Drugs Market Value Share Analysis, by Region
10.2. Global Gynecology Drugs Market Size (US$ Mn) Forecast, by Region
10.3. Global Gynecology Drugs Market Attractiveness Analysis, by Region
11. North America Gynecology Drugs Market Analysis
11.1. Key Findings
11.2. North America Gynecology Drugs Market Overview
11.3. North America Gynecology Drugs Market Value Share Analysis, By Therapeutics Type
11.4. North America Gynecology Drugs Market Forecast, By Therapeutics Type
11.4.1. Hormonal therapy
11.4.2. Non-Hormonal therapy
11.5. North America Gynecology Drugs Market Value Share Analysis, By Indication
11.6. North America Gynecology Drugs Market Forecast, By Indication
11.6.1. Gynecology Cancers
11.6.2. Endometriosis
11.6.3. Female Infertility
11.6.4. Menopausal Disorder
11.6.5. Gynecology Infections
11.6.6. Polycystic Ovary Syndrome
11.6.7. Contraception (Birth Control)
11.6.8. Others
11.7. North America Gynecology Drugs Market Value Share Analysis, By Distribution Channel
11.8. North America Gynecology Drugs Market Forecast, By Distribution Channel
11.8.1. Hospital Pharmacies
11.8.2. Retail Pharmacies
11.8.3. Online Pharmacies
11.9. North America Gynecology Drugs Market Value Share Analysis, by Country
11.10. North America Gynecology Drugs Market Forecast, by Country
11.10.1. U.S.
11.10.2. Canada
11.11. North America Gynecology Drugs Market Analysis, by Country
11.12. U.S. Gynecology Drugs Market Forecast, By Therapeutics Type
11.12.1. Hormonal therapy
11.12.2. Non-Hormonal therapy
11.13. U.S. Gynecology Drugs Market Forecast, By Indication
11.13.1. Gynecology Cancers
11.13.2. Endometriosis
11.13.3. Female Infertility
11.13.4. Menopausal Disorder
11.13.5. Gynecology Infections
11.13.6. Polycystic Ovary Syndrome
11.13.7. Contraception (Birth Control)
11.13.8. Others
11.14. U.S. Gynecology Drugs Market Forecast, By Distribution Channel
11.14.1. Hospital Pharmacies
11.14.2. Retail Pharmacies
11.14.3. Online Pharmacies
11.15. Canada Gynecology Drugs Market Forecast, By Therapeutics Type
11.15.1. Hormonal therapy
11.15.2. Non-Hormonal therapy
11.16. Canada Gynecology Drugs Market Forecast, By Indication
11.16.1. Gynecology Cancers
11.16.2. Endometriosis
11.16.3. Female Infertility
11.16.4. Menopausal Disorder
11.16.5. Gynecology Infections
11.16.6. Polycystic Ovary Syndrome
11.16.7. Contraception (Birth Control)
11.16.8. Others
11.17. Canada Gynecology Drugs Market Forecast, By Distribution Channel
11.17.1. Hospital Pharmacies
11.17.2. Retail Pharmacies
11.17.3. Online Pharmacies
11.18. North America Gynecology Drugs Market Attractiveness Analysis
11.18.1. By Therapeutics Type
11.18.2. By Indication
11.18.3. By Distribution Channel
11.19. PEST Analysis
11.20. Key Trends
11.21. Key Developments
12. Europe Gynecology Drugs Market Analysis
12.1. Key Findings
12.2. Europe Gynecology Drugs Market Overview
12.3. Europe Gynecology Drugs Market Value Share Analysis, By Therapeutics Type
12.4. Europe Gynecology Drugs Market Forecast, By Therapeutics Type
12.4.1. Hormonal therapy
12.4.2. Non-Hormonal therapy
12.5. Europe Gynecology Drugs Market Value Share Analysis, By Indication
12.6. Europe Gynecology Drugs Market Forecast, By Indication
12.6.1. Gynecology Cancers
12.6.2. Endometriosis
12.6.3. Female Infertility
12.6.4. Menopausal Disorder
12.6.5. Gynecology Infections
12.6.6. Polycystic Ovary Syndrome
12.6.7. Contraception (Birth Control)
12.6.8. Others
12.7. Europe Gynecology Drugs Market Value Share Analysis, By Distribution Channel
12.8. Europe Gynecology Drugs Market Forecast, By Distribution Channel
12.8.1. Hospital Pharmacies
12.8.2. Retail Pharmacies
12.8.3. Online Pharmacies
12.9. Europe Gynecology Drugs Market Value Share Analysis, by Country
12.10. Europe Gynecology Drugs Market Forecast, by Country
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Europe Gynecology Drugs Market Analysis, by Country
12.12. Germany Gynecology Drugs Market Forecast, By Therapeutics Type
12.12.1. Hormonal therapy
12.12.2. Non-Hormonal therapy
12.13. Germany Gynecology Drugs Market Forecast, By Indication
12.13.1. Gynecology Cancers
12.13.2. Endometriosis
12.13.3. Female Infertility
12.13.4. Menopausal Disorder
12.13.5. Gynecology Infections
12.13.6. Polycystic Ovary Syndrome
12.13.7. Contraception (Birth Control)
12.13.8. Others
12.14. Germany Gynecology Drugs Market Forecast, By Distribution Channel
12.14.1. Hospital Pharmacies
12.14.2. Retail Pharmacies
12.14.3. Online Pharmacies
12.15. U.K. Gynecology Drugs Market Forecast, By Therapeutics Type
12.15.1. Hormonal therapy
12.15.2. Non-Hormonal therapy
12.16. U.K. Gynecology Drugs Market Forecast, By Indication
12.16.1. Gynecology Cancers
12.16.2. Endometriosis
12.16.3. Female Infertility
12.16.4. Menopausal Disorder
12.16.5. Gynecology Infections
12.16.6. Polycystic Ovary Syndrome
12.16.7. Contraception (Birth Control)
12.16.8. Others
12.17. U.K. Gynecology Drugs Market Forecast, By Distribution Channel
12.17.1. Hospital Pharmacies
12.17.2. Retail Pharmacies
12.17.3. Online Pharmacies
12.18. France Gynecology Drugs Market Forecast, By Therapeutics Type
12.18.1. Hormonal therapy
12.18.2. Non-Hormonal therapy
12.19. France Gynecology Drugs Market Forecast, By Indication
12.19.1. Gynecology Cancers
12.19.2. Endometriosis
12.19.3. Female Infertility
12.19.4. Menopausal Disorder
12.19.5. Gynecology Infections
12.19.6. Polycystic Ovary Syndrome
12.19.7. Contraception (Birth Control)
12.19.8. Others
12.20. France Gynecology Drugs Market Forecast, By Distribution Channel
12.20.1. Hospital Pharmacies
12.20.2. Retail Pharmacies
12.20.3. Online Pharmacies
12.21. Italy Gynecology Drugs Market Forecast, By Therapeutics Type
12.21.1. Hormonal therapy
12.21.2. Non-Hormonal therapy
12.22. Italy Gynecology Drugs Market Forecast, By Indication
12.22.1. Gynecology Cancers
12.22.2. Endometriosis
12.22.3. Female Infertility
12.22.4. Menopausal Disorder
12.22.5. Gynecology Infections
12.22.6. Polycystic Ovary Syndrome
12.22.7. Contraception (Birth Control)
12.22.8. Others
12.23. Italy Gynecology Drugs Market Forecast, By Distribution Channel
12.23.1. Hospital Pharmacies
12.23.2. Retail Pharmacies
12.23.3. Online Pharmacies
12.24. Spain Gynecology Drugs Market Forecast, By Therapeutics Type
12.24.1. Hormonal therapy
12.24.2. Non-Hormonal therapy
12.25. Spain Gynecology Drugs Market Forecast, By Indication
12.25.1. Gynecology Cancers
12.25.2. Endometriosis
12.25.3. Female Infertility
12.25.4. Menopausal Disorder
12.25.5. Gynecology Infections
12.25.6. Polycystic Ovary Syndrome
12.25.7. Contraception (Birth Control)
12.25.8. Others
12.26. Spain Gynecology Drugs Market Forecast, By Distribution Channel
12.26.1. Hospital Pharmacies
12.26.2. Retail Pharmacies
12.26.3. Online Pharmacies
12.27. Rest of Europe Gynecology Drugs Market Forecast, By Therapeutics Type
12.27.1. Hormonal therapy
12.27.2. Non-Hormonal therapy
12.28. Rest of Europe Gynecology Drugs Market Forecast, By Indication
12.28.1. Gynecology Cancers
12.28.2. Endometriosis
12.28.3. Female Infertility
12.28.4. Menopausal Disorder
12.28.5. Gynecology Infections
12.28.6. Polycystic Ovary Syndrome
12.28.7. Contraception (Birth Control)
12.28.8. Others
12.29. Rest of Europe Gynecology Drugs Market Forecast, By Distribution Channel
12.29.1. Hospital Pharmacies
12.29.2. Retail Pharmacies
12.29.3. Online Pharmacies
12.30. Europe Gynecology Drugs Market Attractiveness Analysis
12.30.1. By Therapeutics Type
12.30.2. By Indication
12.30.3. By Distribution Channel
12.31. PEST Analysis
12.32. Key Trends
12.33. Key Developments
13. Asia Pacific Gynecology Drugs Market Analysis
13.1. Key Findings
13.2. Asia Pacific Gynecology Drugs Market Overview
13.3. Asia Pacific Gynecology Drugs Market Value Share Analysis, By Therapeutics Type
13.4. Asia Pacific Gynecology Drugs Market Forecast, By Therapeutics Type
13.4.1. Hormonal therapy
13.4.2. Non-Hormonal therapy
13.5. Asia Pacific Gynecology Drugs Market Value Share Analysis, By Indication
13.6. Asia Pacific Gynecology Drugs Market Forecast, By Indication
13.6.1. Gynecology Cancers
13.6.2. Endometriosis
13.6.3. Female Infertility
13.6.4. Menopausal Disorder
13.6.5. Gynecology Infections
13.6.6. Polycystic Ovary Syndrome
13.6.7. Contraception (Birth Control)
13.6.8. Others
13.7. Asia Pacific Gynecology Drugs Market Value Share Analysis, By Distribution Channel
13.8. Asia Pacific Gynecology Drugs Market Forecast, By Distribution Channel
13.8.1. Hospital Pharmacies
13.8.2. Retail Pharmacies
13.8.3. Online Pharmacies
13.9. Asia Pacific Gynecology Drugs Market Value Share Analysis, by Country
13.10. Asia Pacific Gynecology Drugs Market Forecast, by Country
13.10.1. China
13.10.2. India
13.10.3. Japan
13.10.4. ASEAN
13.10.5. Rest of Asia Pacific
13.11. Asia Pacific Gynecology Drugs Market Analysis, by Country
13.12. China Gynecology Drugs Market Forecast, By Therapeutics Type
13.12.1. Hormonal therapy
13.12.2. Non-Hormonal therapy
13.13. China Gynecology Drugs Market Forecast, By Indication
13.13.1. Gynecology Cancers
13.13.2. Endometriosis
13.13.3. Female Infertility
13.13.4. Menopausal Disorder
13.13.5. Gynecology Infections
13.13.6. Polycystic Ovary Syndrome
13.13.7. Contraception (Birth Control)
13.13.8. Others
13.14. China Gynecology Drugs Market Forecast, By Distribution Channel
13.14.1. Hospital Pharmacies
13.14.2. Retail Pharmacies
13.14.3. Online Pharmacies
13.15. India Gynecology Drugs Market Forecast, By Therapeutics Type
13.15.1. Hormonal therapy
13.15.2. Non-Hormonal therapy
13.16. India Gynecology Drugs Market Forecast, By Indication
13.16.1. Gynecology Cancers
13.16.2. Endometriosis
13.16.3. Female Infertility
13.16.4. Menopausal Disorder
13.16.5. Gynecology Infections
13.16.6. Polycystic Ovary Syndrome
13.16.7. Contraception (Birth Control)
13.16.8. Others
13.17. India Gynecology Drugs Market Forecast, By Distribution Channel
13.17.1. Hospital Pharmacies
13.17.2. Retail Pharmacies
13.17.3. Online Pharmacies
13.18. Japan Gynecology Drugs Market Forecast, By Therapeutics Type
13.18.1. Hormonal therapy
13.18.2. Non-Hormonal therapy
13.19. Japan Gynecology Drugs Market Forecast, By Indication
13.19.1. Gynecology Cancers
13.19.2. Endometriosis
13.19.3. Female Infertility
13.19.4. Menopausal Disorder
13.19.5. Gynecology Infections
13.19.6. Polycystic Ovary Syndrome
13.19.7. Contraception (Birth Control)
13.19.8. Others
13.20. Japan Gynecology Drugs Market Forecast, By Distribution Channel
13.20.1. Hospital Pharmacies
13.20.2. Retail Pharmacies
13.20.3. Online Pharmacies
13.21. ASEAN Gynecology Drugs Market Forecast, By Therapeutics Type
13.21.1. Hormonal therapy
13.21.2. Non-Hormonal therapy
13.22. ASEAN Gynecology Drugs Market Forecast, By Indication
13.22.1. Gynecology Cancers
13.22.2. Endometriosis
13.22.3. Female Infertility
13.22.4. Menopausal Disorder
13.22.5. Gynecology Infections
13.22.6. Polycystic Ovary Syndrome
13.22.7. Contraception (Birth Control)
13.22.8. Others
13.23. ASEAN Gynecology Drugs Market Forecast, By Distribution Channel
13.23.1. Hospital Pharmacies
13.23.2. Retail Pharmacies
13.23.3. Online Pharmacies
13.24. Rest of Asia Pacific Gynecology Drugs Market Forecast, By Therapeutics Type
13.24.1. Hormonal therapy
13.24.2. Non-Hormonal therapy
13.25. Rest of Asia Pacific Gynecology Drugs Market Forecast, By Indication
13.25.1. Gynecology Cancers
13.25.2. Endometriosis
13.25.3. Female Infertility
13.25.4. Menopausal Disorder
13.25.5. Gynecology Infections
13.25.6. Polycystic Ovary Syndrome
13.25.7. Contraception (Birth Control)
13.25.8. Others
13.26. Rest of Asia Pacific Gynecology Drugs Market Forecast, By Distribution Channel
13.26.1. Hospital Pharmacies
13.26.2. Retail Pharmacies
13.26.3. Online Pharmacies
13.27. Asia Pacific Gynecology Drugs Market Attractiveness Analysis
13.27.1. By Therapeutics Type
13.27.2. By Indication
13.27.3. By Distribution Channel
13.28. PEST Analysis
13.29. Key Trends
13.30. Key Developments
14. Middle East & Africa Gynecology Drugs Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Gynecology Drugs Market Overview
14.3. Middle East & Africa Gynecology Drugs Market Value Share Analysis, By Therapeutics Type
14.4. Middle East & Africa Gynecology Drugs Market Forecast, By Therapeutics Type
14.4.1. Hormonal therapy
14.4.2. Non-Hormonal therapy
14.5. Middle East & Africa Gynecology Drugs Market Value Share Analysis, By Indication
14.6. Middle East & Africa Gynecology Drugs Market Forecast, By Indication
14.6.1. Gynecology Cancers
14.6.2. Endometriosis
14.6.3. Female Infertility
14.6.4. Menopausal Disorder
14.6.5. Gynecology Infections
14.6.6. Polycystic Ovary Syndrome
14.6.7. Contraception (Birth Control)
14.6.8. Others
14.7. Middle East & Africa Gynecology Drugs Market Value Share Analysis, By Distribution Channel
14.8. Middle East & Africa Gynecology Drugs Market Forecast, By Distribution Channel
14.8.1. Hospital Pharmacies
14.8.2. Retail Pharmacies
14.8.3. Online Pharmacies
14.9. Middle East & Africa Gynecology Drugs Market Value Share Analysis, by Country
14.10. Middle East & Africa Gynecology Drugs Market Forecast, by Country
14.10.1. GCC
14.10.2. South Africa
14.10.3. Rest of Middle East & Africa
14.11. Middle East & Africa Gynecology Drugs Market Analysis, by Country
14.12. GCC Gynecology Drugs Market Forecast, By Therapeutics Type
14.12.1. Hormonal therapy
14.12.2. Non-Hormonal therapy
14.13. GCC Gynecology Drugs Market Forecast, By Indication
14.13.1. Gynecology Cancers
14.13.2. Endometriosis
14.13.3. Female Infertility
14.13.4. Menopausal Disorder
14.13.5. Gynecology Infections
14.13.6. Polycystic Ovary Syndrome
14.13.7. Contraception (Birth Control)
14.13.8. Others
14.14. GCC Gynecology Drugs Market Forecast, By Distribution Channel
14.14.1. Hospital Pharmacies
14.14.2. Retail Pharmacies
14.14.3. Online Pharmacies
14.15. South Africa Gynecology Drugs Market Forecast, By Therapeutics Type
14.15.1. Hormonal therapy
14.15.2. Non-Hormonal therapy
14.16. South Africa Gynecology Drugs Market Forecast, By Indication
14.16.1. Gynecology Cancers
14.16.2. Endometriosis
14.16.3. Female Infertility
14.16.4. Menopausal Disorder
14.16.5. Gynecology Infections
14.16.6. Polycystic Ovary Syndrome
14.16.7. Contraception (Birth Control)
14.16.8. Others
14.17. South Africa Gynecology Drugs Market Forecast, By Distribution Channel
14.17.1. Hospital Pharmacies
14.17.2. Retail Pharmacies
14.17.3. Online Pharmacies
14.18. Rest of Middle East & Africa Gynecology Drugs Market Forecast, By Therapeutics Type
14.18.1. Hormonal therapy
14.18.2. Non-Hormonal therapy
14.19. Rest of Middle East & Africa Gynecology Drugs Market Forecast, By Indication
14.19.1. Gynecology Cancers
14.19.2. Endometriosis
14.19.3. Female Infertility
14.19.4. Menopausal Disorder
14.19.5. Gynecology Infections
14.19.6. Polycystic Ovary Syndrome
14.19.7. Contraception (Birth Control)
14.19.8. Others
14.20. Rest of Middle East & Africa Gynecology Drugs Market Forecast, By Distribution Channel
14.20.1. Hospital Pharmacies
14.20.2. Retail Pharmacies
14.20.3. Online Pharmacies
14.21. Middle East & Africa Gynecology Drugs Market Attractiveness Analysis
14.21.1. By Therapeutics Type
14.21.2. By Indication
14.21.3. By Distribution Channel
14.22. PEST Analysis
14.23. Key Trends
14.24. Key Developments
15. South America Gynecology Drugs Market Analysis
15.1. Key Findings
15.2. South America Gynecology Drugs Market Overview
15.3. South America Gynecology Drugs Market Value Share Analysis, By Therapeutics Type
15.4. South America Gynecology Drugs Market Forecast, By Therapeutics Type
15.4.1. Hormonal therapy
15.4.2. Non-Hormonal therapy
15.5. South America Gynecology Drugs Market Value Share Analysis, By Indication
15.6. South America Gynecology Drugs Market Forecast, By Indication
15.6.1. Gynecology Cancers
15.6.2. Endometriosis
15.6.3. Female Infertility
15.6.4. Menopausal Disorder
15.6.5. Gynecology Infections
15.6.6. Polycystic Ovary Syndrome
15.6.7. Contraception (Birth Control)
15.6.8. Others
15.7. South America Gynecology Drugs Market Value Share Analysis, By Distribution Channel
15.8. South America Gynecology Drugs Market Forecast, By Distribution Channel
15.8.1. Hospital Pharmacies
15.8.2. Retail Pharmacies
15.8.3. Online Pharmacies
15.9. South America Gynecology Drugs Market Value Share Analysis, by Country
15.10. South America Gynecology Drugs Market Forecast, by Country
15.10.1. Brazil
15.10.2. Mexico
15.10.3. Rest of South America
15.11. South America Gynecology Drugs Market Analysis, by Country
15.12. Brazil Gynecology Drugs Market Forecast, By Therapeutics Type
15.12.1. Hormonal therapy
15.12.2. Non-Hormonal therapy
15.13. Brazil Gynecology Drugs Market Forecast, By Indication
15.13.1. Gynecology Cancers
15.13.2. Endometriosis
15.13.3. Female Infertility
15.13.4. Menopausal Disorder
15.13.5. Gynecology Infections
15.13.6. Polycystic Ovary Syndrome
15.13.7. Contraception (Birth Control)
15.13.8. Others
15.14. Brazil Gynecology Drugs Market Forecast, By Distribution Channel
15.14.1. Hospital Pharmacies
15.14.2. Retail Pharmacies
15.14.3. Online Pharmacies
15.15. Mexico Gynecology Drugs Market Forecast, By Therapeutics Type
15.15.1. Hormonal therapy
15.15.2. Non-Hormonal therapy
15.16. Mexico Gynecology Drugs Market Forecast, By Indication
15.16.1. Gynecology Cancers
15.16.2. Endometriosis
15.16.3. Female Infertility
15.16.4. Menopausal Disorder
15.16.5. Gynecology Infections
15.16.6. Polycystic Ovary Syndrome
15.16.7. Contraception (Birth Control)
15.16.8. Others
15.17. Mexico Gynecology Drugs Market Forecast, By Distribution Channel
15.17.1. Hospital Pharmacies
15.17.2. Retail Pharmacies
15.17.3. Online Pharmacies
15.18. Rest of South America Gynecology Drugs Market Forecast, By Therapeutics Type
15.18.1. Hormonal therapy
15.18.2. Non-Hormonal therapy
15.19. Rest of South America Gynecology Drugs Market Forecast, By Indication
15.19.1. Gynecology Cancers
15.19.2. Endometriosis
15.19.3. Female Infertility
15.19.4. Menopausal Disorder
15.19.5. Gynecology Infections
15.19.6. Polycystic Ovary Syndrome
15.19.7. Contraception (Birth Control)
15.19.8. Others
15.20. Rest of South America Gynecology Drugs Market Forecast, By Distribution Channel
15.20.1. Hospital Pharmacies
15.20.2. Retail Pharmacies
15.20.3. Online Pharmacies
15.21. South America Gynecology Drugs Market Attractiveness Analysis
15.21.1. By Therapeutics Type
15.21.2. By Indication
15.21.3. By Distribution Channel
15.22. PEST Analysis
15.23. Key Trends
15.24. Key Developments
16. Company Profiles
16.1. Market Share Analysis, by Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players by price, presence, market share, Route of Administrations and R&D investment
16.2.2. New Indication Launches and Indication Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A by Regions, Investment and Route of Administrations
16.2.3.2. M&A Key Players, Forward Integration and Backward Integration
16.3. Company Profiles: Key Players
16.3.1. Eli Lilly and Company
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Indication Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Company Footprint
16.3.2. Pfizer, Inc.
16.3.3. Merck & Co., Inc.
16.3.4. Sanofi
16.3.5. Amgen Inc.
16.3.6. Lupin Pharmaceuticals, Inc.
16.3.7. AstraZeneca
16.3.8. F. Hoffmann-La Roche Ltd.
16.3.9. Allergan Plc.
16.3.10. GlaxoSmithKline plc.
16.3.11. Bayer AG
16.3.12. Johnson & Johnson
16.3.13. AbbVie Inc
16.3.14. TherapeuticsMD Inc
16.3.15. Ferring Holding SA
16.3.16. Abbott

17. Primary Key Insights
  • INQUIRE BEFORE BUYING